Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03072043
Title Phase 1b/2 Safety and Efficacy of APR-246 w/Azacitidine for tx of TP53 Mutant Myeloid Neoplasms
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Indications

acute myeloid leukemia

myelodysplastic/myeloproliferative neoplasm

myelodysplastic syndrome

Therapies

APR-246 + Azacitidine

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST